drugset / Trial / NCT06703840
Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are: * Does the drug LIB-01 improve erectile function in males with erectile dysfunction? * What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction. Participants will: * Take the drug LIB-01 or a placebo every day for 3 days * Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests
Timeline
- Start
- 2024-11-08
- Primary completion
- 2025-07-19
- Completion
- 2025-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LIB-01 | Unknown | 10 mg | Oral |
| Subject | LIB-01 | Unknown | 25 mg | Oral |
| Subject | LIB-01 | Unknown | 50 mg | Oral |